tiprankstipranks
Trending News
More News >
Wakamoto Pharmaceutical Co., Ltd. (JP:4512)
:4512
Japanese Market
Advertisement

Wakamoto Pharmaceutical Co., Ltd. (4512) Income Statement

Compare
0 Followers

Wakamoto Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q3 2023), Wakamoto Pharmaceutical Co., Ltd.'s total revenue was ¥1.97B, a decrease of -12.47% from the same quarter last year. In Q3, Wakamoto Pharmaceutical Co., Ltd.'s net income was ¥17.26M. See Wakamoto Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
¥ 7.79B¥ 7.74B¥ 8.66B¥ 8.38B¥ 8.89B
Gross Profit
¥ 3.62B¥ 3.54B¥ 4.11B¥ 4.36B¥ 4.49B
Operating Expenses
¥ 4.08B¥ 3.80B¥ 3.97B¥ 4.37B¥ 5.24B
Depreciation and Amortization
¥ 430.34M¥ 345.45M¥ 363.65M¥ 470.08M¥ 484.31M
EBITDA
¥ 438.68M¥ 504.84M¥ 575.81M¥ 755.52M¥ -218.12M
Operating Income
¥ -457.80M¥ -195.51M¥ 141.47M¥ -13.39M¥ -754.95M
Other Income/Expenses
¥ 465.25M¥ 354.37M¥ 70.11M¥ 298.24M¥ 51.94M
Pretax Income
¥ 7.46M¥ 158.85M¥ 211.57M¥ 284.86M¥ -703.01M
Net Income
¥ 64.44M¥ 108.96M¥ 138.26M¥ 238.54M¥ -601.86M
Per Share Metrics
Basic EPS
¥ 1.86¥ 3.14¥ 3.98¥ 6.87¥ -17.34
Diluted EPS
¥ 1.86¥ 3.14¥ 3.98¥ 6.87¥ -17.34
Weighted Average Shares Outstanding
34.71M 34.71M 34.71M 34.71M 34.71M
Weighted Average Shares Outstanding (Diluted)
34.71M 34.71M 34.71M 34.71M 34.71M
Currency in JPY

Wakamoto Pharmaceutical Co., Ltd. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis